Welcome to our dedicated page for USBC SEC filings (Ticker: USBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The USBC, Inc. (NYSE American: USBC) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries that help explain complex documents in plain language. USBC is a Nevada-incorporated, publicly traded, multi-disciplinary technology company that focuses on digital financial technologies, including tokenized U.S. dollar deposits and a Bitcoin treasury strategy, as well as non-invasive health monitoring research.
Through its registration statements on Form S-1 and S-1/A, USBC outlines its business overview, corporate history, and strategic transition from its legacy non-invasive sensor technology operations as Know Labs, Inc. to a broader financial technology platform. These filings describe the USBC tokenized deposit offering, a U.S.-dollar denominated tokenized representation of a bank deposit account that operates on blockchain technology and is embedded with digital identity, and detail the establishment of a Bitcoin treasury as a primary reserve asset.
Current and prospective investors can review USBC’s Forms 8-K for information on material events, including the strategic investment by Goldeneye 1995 LLC, changes to its equity incentive plans, executive departures and related separation agreements, option repricing and new equity grants, and amendments to digital asset management agreements for its Bitcoin treasury strategy. These filings also document the company’s name and ticker change to USBC, Inc. and “USBC” on the NYSE American.
On Stock Titan, AI-generated insights highlight key sections of USBC’s filings, such as risk factor discussions, descriptions of the tokenized deposit model and Bitcoin treasury program, and details of significant capital transactions. Users can also track updates related to equity compensation plans and governance decisions reported under Item 5.02 of Form 8-K. Real-time integration with EDGAR helps ensure that new USBC filings, including future annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks, are quickly available with concise explanations of their main points.
USBC, Inc. reported that board member John Cronin has resigned from the company’s Board of Directors, effective November 19, 2025. The company states that his decision to step down was not due to any disagreement with USBC or its management regarding operations, policies, or practices. The filing is focused solely on this governance change and does not disclose any related strategic or financial developments.
USBC, Inc. filed a Form S-8 to register an aggregate 65,000,000 additional shares of common stock issuable under its Amended and Restated 2021 Equity Incentive Plan, following stockholder approval on September 29, 2025.
The filing incorporates prior S-8 registrations, including 500,000 shares under the 2021 plan and 366,253 shares reserved under the 2011 plan (as adjusted), plus 550,000 shares and 48,950,000 shares registered earlier in 2025. It also notes a 1-for-40 reverse stock split effective February 19, 2025, which adjusted historical plan amounts.
USBC, Inc. reporting person Kitty B. Payne, who serves as CFO/Treasurer/Secretary and a director, disclosed option activity on 10/07/2025. The Board approved a repricing that reduced the exercise price on 1,790,000 outstanding options from $2.45 to $1.10. The reporting person also received a new grant of 1,960,000 options exercisable at $1.10. After these transactions the reporting person beneficially owns 3,750,000 underlying shares via options, all exercisable through 2035 with standard vesting of 25% after one year and quarterly installments over three years thereafter.
The repricing and new grant increase the reporting persons option exposure and lower near-term strike prices, which may affect dilution and align executive incentives with current share value. All terms disclosed are pursuant to the Amended and Restated 2021 Equity Incentive Plan.
Insider option activity: A director, Linda Jenkinson, reported option repricings and new grants on 10/07/2025 for USBC, Inc. The Board approved lowering the exercise price of previously granted options from $2.45 to $1.10 for 4,760,000 shares. The reporting person also received two option grants: one repriced option covering 4,760,000 shares and a new option for 5,240,000 shares, creating total option exposure to 10,000,000 underlying shares exercisable through 2035. Each option vests 25% after one year then quarterly over three years.
USBC insider option activity: The company's Chief Operating Officer participated in targeted option adjustments and a new grant. Outstanding options covering 7,140,000 shares were repriced from $2.45 to $1.10 and remain subject to the original vesting schedule that vests 25% after one year with quarterly vesting thereafter. In addition, a new option for 7,860,000 shares was granted at an exercise price of $1.10 with the same vesting pattern, producing a total of 15,000,000 underlying shares held after the transactions. The repriced and newly granted options have exercise windows stretching to 2035 and carry standard multi-year vesting to align with future service.
USBC, Inc. reported that its board approved an option repricing and new equity grants under the Amended and Restated 2021 Equity Incentive Plan. On October 7, 2025, the exercise price of previously granted options covering 48,620,000 shares was reduced from $2.45 to $1.10 per share, the closing price of the company’s common stock that day. These repriced awards include options held by named executive officers and directors, such as 1,790,000 shares for the CFO, 7,140,000 for the COO, and 4,760,000 for a director. The board also granted new ten-year stock options covering 55,030,000 shares at $1.10 per share, which vest 25% between three months and one year from grant and quarterly over the following three years for continued service. Named executives received new grants including 1,960,000 shares for the CFO, 7,860,000 for the COO, and 5,240,000 for the director.
USBC, Inc. reported results from its latest Annual Meeting of Stockholders. Shareholders approved an Amended and Restated 2021 Equity Incentive Plan that increases the number of shares of common stock authorized for issuance under the plan by 65,000,000 shares, allows the board or compensation committee to expressly permit repricing and exchanges of awards to help maintain incentive and retention value, and revises the evergreen provision so the automatic annual increase is 15,000,000 shares.
All eight director nominees were elected with more than 364.8 million votes cast for each. Shareholders also ratified the appointment of BPM, LLP as independent registered public accounting firm for the fiscal year ending September 30, 2025. As of the August 18, 2025 record date, 384,234,130 shares of common stock were outstanding, and 368,214,275 shares, or 95.83% of the outstanding common stock, were represented at the meeting, satisfying quorum requirements.
Amendment No. 1 to Schedule 13D reports that Robert Gregory Kidd and Goldeneye 1995 LLC hold an aggregate of 357,815,000 shares of USBC, Inc. common stock, representing approximately 92.1% of the 388,143,679 shares outstanding as of September 15, 2025. The filing states Mr. Kidd and Goldeneye each have sole voting and dispositive power over these shares. On September 19, 2025 the parties entered into a Registration Rights Agreement and the issuer filed a Form S-1 covering resale of the shares issued to Goldeneye in the private placement. No other transactions in the prior 60 days were reported.
Amendment No. 1 to Schedule 13D reports that Robert Gregory Kidd and Goldeneye 1995 LLC hold an aggregate of 357,815,000 shares of USBC, Inc. common stock, representing approximately 92.1% of the 388,143,679 shares outstanding as of September 15, 2025. The filing states Mr. Kidd and Goldeneye each have sole voting and dispositive power over these shares. On September 19, 2025 the parties entered into a Registration Rights Agreement and the issuer filed a Form S-1 covering resale of the shares issued to Goldeneye in the private placement. No other transactions in the prior 60 days were reported.
Amendment No. 1 to Schedule 13D reports that Robert Gregory Kidd and Goldeneye 1995 LLC hold an aggregate of 357,815,000 shares of USBC, Inc. common stock, representing approximately 92.1% of the 388,143,679 shares outstanding as of September 15, 2025. The filing states Mr. Kidd and Goldeneye each have sole voting and dispositive power over these shares. On September 19, 2025 the parties entered into a Registration Rights Agreement and the issuer filed a Form S-1 covering resale of the shares issued to Goldeneye in the private placement. No other transactions in the prior 60 days were reported.
Amendment No. 1 to Schedule 13D reports that Robert Gregory Kidd and Goldeneye 1995 LLC hold an aggregate of 357,815,000 shares of USBC, Inc. common stock, representing approximately 92.1% of the 388,143,679 shares outstanding as of September 15, 2025. The filing states Mr. Kidd and Goldeneye each have sole voting and dispositive power over these shares. On September 19, 2025 the parties entered into a Registration Rights Agreement and the issuer filed a Form S-1 covering resale of the shares issued to Goldeneye in the private placement. No other transactions in the prior 60 days were reported.
Amendment No. 1 to Schedule 13D reports that Robert Gregory Kidd and Goldeneye 1995 LLC hold an aggregate of 357,815,000 shares of USBC, Inc. common stock, representing approximately 92.1% of the 388,143,679 shares outstanding as of September 15, 2025. The filing states Mr. Kidd and Goldeneye each have sole voting and dispositive power over these shares. On September 19, 2025 the parties entered into a Registration Rights Agreement and the issuer filed a Form S-1 covering resale of the shares issued to Goldeneye in the private placement. No other transactions in the prior 60 days were reported.
USBC, Inc. is registering 367,634,098 shares of common stock for resale by existing stockholders, including shares issued in a large August 2025 private placement and related advisor and consultant compensation. USBC will not receive any proceeds from these resale transactions.
As of September 15, 2025, USBC had 388,143,679 shares of common stock outstanding. The company has strategically shifted from solely sensor technology toward a multi‑disciplinary model combining non‑invasive medical technology with digital‑asset and banking initiatives, including a Bitcoin treasury of about 1,000 Bitcoin and development of the USBC token. USBC also maintains an at‑the‑market equity program under a separate Form S‑3 shelf, with up to $14.5 million of stock available for sale through JonesTrading.
USBC, Inc. is registering 367,634,098 shares of common stock for resale by existing stockholders, including shares issued in a large August 2025 private placement and related advisor and consultant compensation. USBC will not receive any proceeds from these resale transactions.
As of September 15, 2025, USBC had 388,143,679 shares of common stock outstanding. The company has strategically shifted from solely sensor technology toward a multi‑disciplinary model combining non‑invasive medical technology with digital‑asset and banking initiatives, including a Bitcoin treasury of about 1,000 Bitcoin and development of the USBC token. USBC also maintains an at‑the‑market equity program under a separate Form S‑3 shelf, with up to $14.5 million of stock available for sale through JonesTrading.
USCB Financial Holdings is updating its at-the-market stock offering program, allowing it to offer and sell shares of common stock with an aggregate offering price of up to $14,500,000 through JonesTrading Institutional Services under an existing sales agreement. The company states that its public float is now above $75.0 million, so it is no longer subject to the Form S-3 General Instruction I.B.6 sales limitations for this registration. As of September 2, 2025, public float was $87,168,697, based on 23,622,953 shares held by non-affiliates at a price of $3.69 per share, the closing price on July 8, 2025. The common stock trades on the NYSE American under the symbol USBC, and the last reported sale price on September 4, 2025 was $0.74 per share.